1. Home
  2. OKTA vs HOLX Comparison

OKTA vs HOLX Comparison

Compare OKTA & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okta Inc.

OKTA

Okta Inc.

N/A

Current Price

$85.31

Market Cap

15.0B

Sector

Technology

ML Signal

N/A

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$75.00

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKTA
HOLX
Founded
2009
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Electronics
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
16.6B
IPO Year
2017
1990

Fundamental Metrics

Financial Performance
Metric
OKTA
HOLX
Price
$85.31
$75.00
Analyst Decision
Buy
Hold
Analyst Count
37
13
Target Price
$116.86
$77.89
AVG Volume (30 Days)
2.6M
2.7M
Earning Date
03-04-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.08
2.40
Revenue
$2,840,000,000.00
$4,126,500,000.00
Revenue This Year
$13.64
$6.01
Revenue Next Year
$9.10
$5.29
P/E Ratio
$78.98
$31.17
Revenue Growth
12.12
2.17
52 Week Low
$75.05
$51.90
52 Week High
$127.57
$75.36

Technical Indicators

Market Signals
Indicator
OKTA
HOLX
Relative Strength Index (RSI) 45.27 55.34
Support Level $83.36 $74.89
Resistance Level $89.79 $75.26
Average True Range (ATR) 3.57 0.43
MACD -0.13 0.00
Stochastic Oscillator 44.09 90.26

Price Performance

Historical Comparison
OKTA
HOLX

About OKTA Okta Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: